Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men

Sundeep Khosla, B. Lawrence Riggs, Elizabeth J. Atkinson, Ann L Oberg, Carmelo Mavilia, Francesca Del Monte, L. Joseph Melton, Maria Luisa Brandi

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Estrogen is now known to play an important role in bone metabolism in men. Thus, we examined possible relationships between polymorphisms of the estrogen receptor (ER)-α and -β genes, bone mineral density (BMD), and rates of bone loss in an age-stratified random sample of 283 Rochester, Minnesota, men aged 22-90 yr. DNA was analyzed for the XbaI and PvuII ER-α and AluI EB-β polymorphisms. The X/P and x/p alleles of the ER-α gene were in strong linkage disequilibrium. BMD at multiple sites did not differ as a function of either the ER-α or -β genotype. However, the ER-α (but not ER-β) genotypes did modulate the previously described relationships between BMD or rates of bone loss and bioavailable estradiol (E 2) levels in these men. At the femoral neck, BMD was associated with bioavailable E 3 levels in men with the XX (R = 0.66) or PP (R = 0.51) genotypes (P < 0.001 for both) but not in men with the xx (R = 0.15; P = 0.188) or pp (R = 0.12; P = 0.356) genotypes. The interactions between bioavailable E 2 levels and the XbaI and PvuII genotypes were significant at the P < 0.001 and P < 0.009 levels, respectively. Moreover, rates of bone loss at the midradius in men aged 60 -90 yr were modestly correlated with serum bioavailable E 2 levels in subjects with the X (R = 0.47) or P (R = 0.42) alleles (P < 0.001 for both) but not in those with the xx (R = 0.15; P = 0.430) or pp (R = 0.21; P = 0.372) genotypes. The overall effect of genotype on midradius rate of bone loss was clearly significant for the XbaI polymorphism (P = 0.009) when bioavailable E 2 levels were low (<40 pmol/liter) but not for the PvuII polymorphism. These data thus indicate that the ER-α genotype may modulate the relationship between BMD or rates of bone loss and estrogen levels in men and that bone mass in men with the X or P alleles may be more susceptible to the consequences of estrogen deficiency (and conversely, benefit most from estrogen sufficiency) than in men with the xx or pp genotypes.

Original languageEnglish (US)
Pages (from-to)1808-1816
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume89
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Estrogen Receptors
Bone Density
Minerals
Bone
Genotype
Bone and Bones
Estrogens
Polymorphism
Alleles
Genes
Femur Neck
Linkage Disequilibrium
Estradiol
Metabolism
DNA
Serum

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men. / Khosla, Sundeep; Riggs, B. Lawrence; Atkinson, Elizabeth J.; Oberg, Ann L; Mavilia, Carmelo; Del Monte, Francesca; Melton, L. Joseph; Brandi, Maria Luisa.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 89, No. 4, 04.2004, p. 1808-1816.

Research output: Contribution to journalArticle

Khosla, Sundeep ; Riggs, B. Lawrence ; Atkinson, Elizabeth J. ; Oberg, Ann L ; Mavilia, Carmelo ; Del Monte, Francesca ; Melton, L. Joseph ; Brandi, Maria Luisa. / Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men. In: Journal of Clinical Endocrinology and Metabolism. 2004 ; Vol. 89, No. 4. pp. 1808-1816.
@article{594e119140744299b871b5b81e8ce10d,
title = "Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men",
abstract = "Estrogen is now known to play an important role in bone metabolism in men. Thus, we examined possible relationships between polymorphisms of the estrogen receptor (ER)-α and -β genes, bone mineral density (BMD), and rates of bone loss in an age-stratified random sample of 283 Rochester, Minnesota, men aged 22-90 yr. DNA was analyzed for the XbaI and PvuII ER-α and AluI EB-β polymorphisms. The X/P and x/p alleles of the ER-α gene were in strong linkage disequilibrium. BMD at multiple sites did not differ as a function of either the ER-α or -β genotype. However, the ER-α (but not ER-β) genotypes did modulate the previously described relationships between BMD or rates of bone loss and bioavailable estradiol (E 2) levels in these men. At the femoral neck, BMD was associated with bioavailable E 3 levels in men with the XX (R = 0.66) or PP (R = 0.51) genotypes (P < 0.001 for both) but not in men with the xx (R = 0.15; P = 0.188) or pp (R = 0.12; P = 0.356) genotypes. The interactions between bioavailable E 2 levels and the XbaI and PvuII genotypes were significant at the P < 0.001 and P < 0.009 levels, respectively. Moreover, rates of bone loss at the midradius in men aged 60 -90 yr were modestly correlated with serum bioavailable E 2 levels in subjects with the X (R = 0.47) or P (R = 0.42) alleles (P < 0.001 for both) but not in those with the xx (R = 0.15; P = 0.430) or pp (R = 0.21; P = 0.372) genotypes. The overall effect of genotype on midradius rate of bone loss was clearly significant for the XbaI polymorphism (P = 0.009) when bioavailable E 2 levels were low (<40 pmol/liter) but not for the PvuII polymorphism. These data thus indicate that the ER-α genotype may modulate the relationship between BMD or rates of bone loss and estrogen levels in men and that bone mass in men with the X or P alleles may be more susceptible to the consequences of estrogen deficiency (and conversely, benefit most from estrogen sufficiency) than in men with the xx or pp genotypes.",
author = "Sundeep Khosla and Riggs, {B. Lawrence} and Atkinson, {Elizabeth J.} and Oberg, {Ann L} and Carmelo Mavilia and {Del Monte}, Francesca and Melton, {L. Joseph} and Brandi, {Maria Luisa}",
year = "2004",
month = "4",
doi = "10.1210/jc.2003-031448",
language = "English (US)",
volume = "89",
pages = "1808--1816",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men

AU - Khosla, Sundeep

AU - Riggs, B. Lawrence

AU - Atkinson, Elizabeth J.

AU - Oberg, Ann L

AU - Mavilia, Carmelo

AU - Del Monte, Francesca

AU - Melton, L. Joseph

AU - Brandi, Maria Luisa

PY - 2004/4

Y1 - 2004/4

N2 - Estrogen is now known to play an important role in bone metabolism in men. Thus, we examined possible relationships between polymorphisms of the estrogen receptor (ER)-α and -β genes, bone mineral density (BMD), and rates of bone loss in an age-stratified random sample of 283 Rochester, Minnesota, men aged 22-90 yr. DNA was analyzed for the XbaI and PvuII ER-α and AluI EB-β polymorphisms. The X/P and x/p alleles of the ER-α gene were in strong linkage disequilibrium. BMD at multiple sites did not differ as a function of either the ER-α or -β genotype. However, the ER-α (but not ER-β) genotypes did modulate the previously described relationships between BMD or rates of bone loss and bioavailable estradiol (E 2) levels in these men. At the femoral neck, BMD was associated with bioavailable E 3 levels in men with the XX (R = 0.66) or PP (R = 0.51) genotypes (P < 0.001 for both) but not in men with the xx (R = 0.15; P = 0.188) or pp (R = 0.12; P = 0.356) genotypes. The interactions between bioavailable E 2 levels and the XbaI and PvuII genotypes were significant at the P < 0.001 and P < 0.009 levels, respectively. Moreover, rates of bone loss at the midradius in men aged 60 -90 yr were modestly correlated with serum bioavailable E 2 levels in subjects with the X (R = 0.47) or P (R = 0.42) alleles (P < 0.001 for both) but not in those with the xx (R = 0.15; P = 0.430) or pp (R = 0.21; P = 0.372) genotypes. The overall effect of genotype on midradius rate of bone loss was clearly significant for the XbaI polymorphism (P = 0.009) when bioavailable E 2 levels were low (<40 pmol/liter) but not for the PvuII polymorphism. These data thus indicate that the ER-α genotype may modulate the relationship between BMD or rates of bone loss and estrogen levels in men and that bone mass in men with the X or P alleles may be more susceptible to the consequences of estrogen deficiency (and conversely, benefit most from estrogen sufficiency) than in men with the xx or pp genotypes.

AB - Estrogen is now known to play an important role in bone metabolism in men. Thus, we examined possible relationships between polymorphisms of the estrogen receptor (ER)-α and -β genes, bone mineral density (BMD), and rates of bone loss in an age-stratified random sample of 283 Rochester, Minnesota, men aged 22-90 yr. DNA was analyzed for the XbaI and PvuII ER-α and AluI EB-β polymorphisms. The X/P and x/p alleles of the ER-α gene were in strong linkage disequilibrium. BMD at multiple sites did not differ as a function of either the ER-α or -β genotype. However, the ER-α (but not ER-β) genotypes did modulate the previously described relationships between BMD or rates of bone loss and bioavailable estradiol (E 2) levels in these men. At the femoral neck, BMD was associated with bioavailable E 3 levels in men with the XX (R = 0.66) or PP (R = 0.51) genotypes (P < 0.001 for both) but not in men with the xx (R = 0.15; P = 0.188) or pp (R = 0.12; P = 0.356) genotypes. The interactions between bioavailable E 2 levels and the XbaI and PvuII genotypes were significant at the P < 0.001 and P < 0.009 levels, respectively. Moreover, rates of bone loss at the midradius in men aged 60 -90 yr were modestly correlated with serum bioavailable E 2 levels in subjects with the X (R = 0.47) or P (R = 0.42) alleles (P < 0.001 for both) but not in those with the xx (R = 0.15; P = 0.430) or pp (R = 0.21; P = 0.372) genotypes. The overall effect of genotype on midradius rate of bone loss was clearly significant for the XbaI polymorphism (P = 0.009) when bioavailable E 2 levels were low (<40 pmol/liter) but not for the PvuII polymorphism. These data thus indicate that the ER-α genotype may modulate the relationship between BMD or rates of bone loss and estrogen levels in men and that bone mass in men with the X or P alleles may be more susceptible to the consequences of estrogen deficiency (and conversely, benefit most from estrogen sufficiency) than in men with the xx or pp genotypes.

UR - http://www.scopus.com/inward/record.url?scp=1942440501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942440501&partnerID=8YFLogxK

U2 - 10.1210/jc.2003-031448

DO - 10.1210/jc.2003-031448

M3 - Article

C2 - 15070949

AN - SCOPUS:1942440501

VL - 89

SP - 1808

EP - 1816

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -